Oct 24, 2026 07:30PM
Oct 24, 2026 07:30PM
Oct 23, 2026 04:04PM
Oct 23, 2026 04:01PM
Oct 2, 2026 09:30AM
Oct 2, 2026 09:30AM
Sep 3, 2026 07:00AM Climb Bio reports Phase 1 data for CLYM116 in IgA nephropathy
Sep 3, 2026 07:00AM
Aug 6, 2026 07:00AM
Aug 4, 2026 01:41PM
Jun 11, 2026 07:00AM
Jun 11, 2026 07:00AM
Jun 5, 2026 07:00AM
Jun 5, 2026 07:00AM Climb Bio Presents CLYM116 Initial Phase 1 Safety Data and Translational Modeling Results at European Renal Association (ERA) Congress 2026 Supporting Continued Development
May 26, 2026 07:00AM
May 14, 2026 07:00AM
May 7, 2026 07:00AM
May 5, 2026 07:04AM
May 5, 2026 07:00AM
May 5, 2026 07:00AM
May 5, 2026 03:08AM Chardan Starts Climb Bio (CLYM) at Buy
Apr 28, 2026 07:00AM
Apr 28, 2026 07:00AM
Apr 8, 2026 07:00AM
Apr 8, 2026 07:00AM
Apr 7, 2026 05:54PM
Apr 7, 2026 09:54AM
Apr 7, 2026 07:00AM Climb Bio receives FDA fast track designation for kidney disease drug
Apr 7, 2026 07:00AM
Apr 7, 2026 07:00AM
Mar 5, 2026 07:00AM
Jan 8, 2026 07:05AM
Jan 8, 2026 07:00AM
Nov 6, 2025 07:01AM
Oct 21, 2025 07:00AM Climb Bio names Adam Villa, Ashley Jones to senior VP roles
Oct 21, 2025 07:00AM
Oct 21, 2025 07:00AM
Oct 17, 2025 07:00AM
Oct 1, 2025 07:00AM
Oct 1, 2025 07:00AM
Sep 30, 2025 07:16AM
Sep 29, 2025 07:01AM Climb Bio reports preclinical data for IgAN drug candidate
Sep 29, 2025 07:00AM
Sep 4, 2025 07:00AM
Aug 12, 2025 07:00AM
Jun 18, 2025 07:01AM
Jun 18, 2025 07:00AM
May 14, 2025 07:00AM
Apr 1, 2025 07:03AM Climb Bio (CLYM) Appoints Kim Cobleigh Drapkin and Bo Cumbo to its Board
Apr 1, 2025 07:00AM

335,360 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All